Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Oxidative Stress Detection Market Growth at CAGR of 9.28%, 2016-2020: Challenges, Trends & Drivers - Key Vendors are Abcam, EMD Millipore, Promega, Qiagen & Thermo Fisher Scientific - Research and Markets

Research and Markets
Posted on: 11 Oct 16

Research and Markets has announced the addition of the "Global Oxidative Stress Detection Market 2016-2020" report to their offering.

Oxidative stress is a state of imbalance caused in cells when a free radical or a reactive oxygen species takes an electron from a molecule and causes a chain reaction leading to cell and tissue damage. Oxidative stress is common in all living organisms and is acceptable to a certain level, beyond which it leads to several biological imbalances and disorders due to the damage it causes to the proteins, lipids, and the DNA in the cells. The condition is usually controlled by the introduction of antioxidants into the body.

The global oxidative stress detection market to grow at a CAGR of 9.28% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global oxidative stress detection market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of instruments, reagents, and services provided for oxidative stress detection process. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the key drivers for market growth will be rapid growth of end-user industries. The primary end-users of oxidative stress assays are the healthcare industry, pharmaceutical industry, and research institutes. The global pharmaceutical industry will grow at a CAGR of 8.8% between 2015 and 2020, with growing investments in drug discovery and detection. Within the pharmaceutical industry, biopharmaceutical and biotechnology sectors are the major users of oxidative stress assays.

The biopharmaceutical sector will grow at a CAGR of 9.8%, followed by biotechnology with 8.6% during the forecast period. Another area of importance for oxidative stress detection is healthcare diagnostics, which has been gaining importance over the past five years and improving its infrastructure since 2010 in most countries. The steady growth of these end-users of oxidative stress assays will drive the demand for these products and solutions during the forecast period.

Key vendors

  • Abcam
  • EMD Millipore
  • Promega
  • Qiagen
  • Thermo Fisher Scientific

Other prominent vendors

  • Amsbio
  • Bio-Rad
  • BioVision
  • Cell Biolabs
  • Cell Signaling Technology
  • Enzo Biochem
  • Genova Diagnostics
  • Rel Assay Diagnostics
  • Sigma-Aldrich
  • tebu-bio

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by end-user

Part 08: Geographical segmentation

Part 09: Market drivers

Part 10: Impact of drivers

Part 11: Market challenges

Part 12: Impact of drivers and challenges

Part 13: Market trends

Part 14: Vendor landscape

Part 15: Key vendor analysis

For more information about this report visit

View source version on

Business Wire

Last updated on: 11/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.